![]() |
NDI-091143
- 英文名称:NDI-091143
- 品牌:WYTSCI
- 产地:进口
- 型号:1MG
- 货号:WT-AY-B11435
- cas:2375840-87-0
- 价格: ¥1/mg
- 发布日期: 2025-04-10
- 更新日期: 2025-04-30
产品详请
产地 | 进口 |
品牌 | WYTSCI |
货号 | WT-AY-B11435 |
用途 | 科研检测 |
英文名称 | NDI-091143 |
包装规格 | 1MG |
CAS编号 | 2375840-87-0 |
别名 | NDI-091143 |
纯度 | 98+% |
分子式 | |
是否进口 | 是 |
纯度:>98% by HPLC;NMR (Conforms)
分子式:C20H14ClF2NO5S
分子量:453.84
溶剂:DMSO (>50 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Potent allosteric ATP-citrate lyase inhibitor
Function / Pharmacology:Potent (IC50 = 2.1 nM ADP-Glo assay; 4.8 nM Oxaloacetate coupled enzyme assay) allosteric inhibitor of ATP-citrate lyase.1 NDI-091143 suppressed growth and clonogenic ability in thyroid cancer cell lines FTC-133 and 8505C.2 It also synergistically potentiated the cytotoxicity of sorafenib.2
分子式:C20H14ClF2NO5S
分子量:453.84
溶剂:DMSO (>50 mg/ml)
性状:Off-white solid
存储:-20°C
Activity (short version):Potent allosteric ATP-citrate lyase inhibitor
Function / Pharmacology:Potent (IC50 = 2.1 nM ADP-Glo assay; 4.8 nM Oxaloacetate coupled enzyme assay) allosteric inhibitor of ATP-citrate lyase.1 NDI-091143 suppressed growth and clonogenic ability in thyroid cancer cell lines FTC-133 and 8505C.2 It also synergistically potentiated the cytotoxicity of sorafenib.2